Organization | Cold Spring Harbor Laboratory

Cold Spring Harbor Laboratory Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial

2014

NCT02241187

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Cold Spring Harbor Laboratory

Active Ingredients

Drugs in Phase 2 Trials (6)

cisplatin (platinol) (1 trial)

famotidine (pepcid) (1 trial)

folfirinox (1 trial)

gemcitabine (gemzar) (2 trials)

paclitaxel (taxol) (2 trials)

vitamin c (1 trial)

Drugs in Other Trials (2)

cetuximab (erbitux) (1 trial)

pegph20 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 2)

Pancreatic Neoplasms (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 4
# of Trial APIs: 8